Brief: aTyr Pharma Announces Q2 2022 Results And Provides Corporate Update
15/08/2022 21:37
Aug 15 (Reuters) - aTyr Pharma Inc LIFE.O :
* ATYR PHARMA ANNOUNCES SECOND QUARTER 2022 RESULTS AND
PROVIDES
CORPORATE UPDATE
* ATYR PHARMA INC - ENDED Q2 2022 WITH $89.3 MILLION IN
CASH,
RESTRICTED CASH, CASH EQUIVALENTS AND INVESTMENTS
* ATYR PHARMA INC - QTRLY LOSS PER SHARE $0.44
Source text for Eikon: ID:nGNX8QBxWs
Further company coverage: LIFE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on aTyr Pharma
See all newsBrief: Atyr Pharma Announces Research Collaboration With Montefiore Einstein
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry
aTyr rises as FDA aligns on late-stage lung disease study plan